Alcon licenses POT-4 from Potentia

Potentia Pharmaceuticals Inc. (Louisville, Ky.) granted Alcon Inc. (NYSE:ACL) exclusive, worldwide rights to POT-4, as well as an option to acquire the ophthalmic biotech. The synthetic peptide C3 inh...